TGCT & Me was developed by Remepy in partnership with EMD Serono and informed by insights from TGCT Support.
This app reflects input from people living with TGCT and healthcare professionals, with the goal of capturing realworld experiences and needs of the TGCT community.
Remepy is a digital health company that designs and develops Hybrid Drugs.
EMD Serono is the U.S.-based healthcare business of Merck KGaA, Darmstadt, Germany.
TGCT Support is a patient advocacy organization dedicated to supporting people affected by TGCT.